Navigation Links
Measuring the impact of post-genomics on Mediterranean populations

A recent Genomed-Health 2005 workshop in Tunisia, supported by the European Commission, highlighted the role of the life sciences in improving health in countries bordering the Mediterranean Sea. Delegates at the event also discussed the importance of Euro-Mediterranean partnerships in order to capitalise on post-genomic research.

The life sciences ?in particular following the mapping of the human genome ?offer vast opportunities to improve scientific knowledge and approaches to improving human health and welfare. The workshop, organised by the Pasteur Institute in Tunisia earlier this month, set out to explore how discoveries in this field can help the Mediterranean region.

Once research priorities were identified, delegates went onto to explore which mechanisms would best serve Euro-Mediterranean partnerships in the health research domain. The workshop also laid the groundwork for networks of potential partners to meet and discuss project ideas they could submit in answer to the December 2004 call for proposals under the INCO-MPC (International Co-operation-Mediterranean Partner Countries) scheme.

Under the Sixth Framework Programme’s (FP6) ‘Specific measures in support of international co-operation? project proposals from MPCs are being sought to help the European Union integrate and strengthen the European Research Area, as outlined in FP6. Ideas for coordinated actions (CAs), specific targeted research projects (Streps), specific support actions (SSAs) are welcomed and, according to the Genomed-Health website, all areas of the FP6 thematic priority one, ‘Life sciences, genomics and biotechnology for health?are open to INCO partners.

Biotech for health
The workshop organisers explained to delegates that the aim of this research priority, among others, is to help exploit ?in this post-genomic era ?the “unprecedented opportunities for generating new knowledge and translating it into applications that enhance human health? To ac hieve this, they continue, fundamental and applied research is needed and supported, stressing integrated, multidisciplinary and coordinated effort.

The two-day workshop highlighted not only the impact of recent progress in genomics on human health in developing countries, but also identified the ethical, social and legal issues (including intellectual property rights, IPR) underpinning this important scientific development. Samir Brahmachari of India’s Institute of Genomics and Integrative Biology (IGIB), kicked off day one (4 March) with his keynote address called ‘Predictive medicine and health research in the post-genomic era?

Later on day one, Ayoade Oduola of the World Health Organisation, asked “How can we tackle the ‘genomic divide?between the developed and developing nations??Following up on this theme, Maxime Seligman of France discussed the ‘North-South co-operation and ethical issues?in genomic research.

The second day of the workshop (5 March) focused more closely on health research in the context of the EU-MPC partnership. Michel Pletschette, representing the Research Directorate-General, which helped support the event, gave an overview of the EU-MPC programme: its past, present and future. Round table discussions were organised later that day on how the EU-MPC co-operation is working to alleviate communicable and non-communicable diseases in the region.


'"/>

Source:EUROPA-Research


Related biology news :

1. Measuring hormone cuts antibiotic use in half in pneumonia patients
2. Measuring Enzymes At End Of Cancer Pathway Predicts Outcome Of Tarceva, Taxol
3. Measuring hidden parasites in falciparum malaria
4. Measuring artery repair cells could become new heart disease test
5. Researchers reveal the infectious impact of salmon farms on wild salmon
6. Second messenger NAADP shows fast, dose-related impact on satiety cycle
7. The first impact factor for PLoS Biology ?13.9
8. Open Access journals get impressive impact factors
9. OHSU research shows vitamin C counteracts some negative impacts of smoking on unborn babies
10. York scientists warn of dramatic impact of climate change on Africa
11. Old drug, new tricks: Prospects for slashing the impact of malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/25/2016)... 2016  Glencoe Software, the world-leading supplier of image ... will provide the data management solution OMERO Plus for ... Photo - ... Phenotypic analysis measures the characteristics and behavior ... between states such as health and disease, the presence ...
(Date:1/20/2016)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce the attainment of record-setting ... result of the company,s laser focus on (and growing ... it,s comprehensive, easy-to-use and highly affordable cloud-based technology platform. ... MedNet growth achievements in 2015 include: , ...
(Date:1/13/2016)... DUBLIN , January 13, 2016 ... has announced the addition of the  ... - Estimation & Forecast (2015-2020)" ... http://www.researchandmarkets.com/research/7h6hnn/india_biometrics ) has announced the ... & Identification Market - Estimation & ...
Breaking Biology News(10 mins):
(Date:2/8/2016)... SHELTON, Conn. , Feb. 8, 2016  NanoViricides, Inc. (NYSE ... that its CEO, Eugene Seymour , MD, MPH, will present ... 5:30PM at the Waldorf-Astoria Hotel in New York City ... presentation will be in the Windsor Room at 5:30PM EST. Registered ... New York City . --> ...
(Date:2/8/2016)... --> --> ... Point-Of-Care (POC) molecular diagnostics company, today announces that it has ... to be launched on the Company,s io® platform. By meeting ... is now cleared for sale within the European Union. ... the io® CT test signals a new era in ultra-rapid ...
(Date:2/5/2016)... , Feb. 5, 2016 ATCC, the premier ... to assist the medical and life science researchers that ... Virus infection.   CDC website . ... Zika virus is a single-stranded RNA virus of ... West Nile, Dengue and Chikungunya Viruses. Zika virus is ...
(Date:2/5/2016)... 5, 2016 Amarantus BioScience Holdings, ... focused on developing products for Regenerative Medicine, Neurology and ... Disease Designation (RPDD) from the US Food and Drug ... MANF was previously granted orphan drug designation (ODD) by ... Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), ...
Breaking Biology Technology: